Page last updated: 2024-08-21

pyrazines and bms 754807

pyrazines has been researched along with bms 754807 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Fogarty, FM; Kennedy, RD; Lyons, A; McCabe, N; O'Connor, R; O'Flanagan, CH; O'Shea, S1
Axelrod, MJ; Bekiranov, S; David, AP; Donaldson, L; Dougherty, MI; Frierson, HF; Gioeli, DG; Hubbard, MA; Jameson, MJ; Khalil, AA; Lehman, CE; McGarey, PO; Mendez, RE; Petricoin, EF; Schoeff, SS; Stelow, EB; Taniguchi, LE; Wulfkuhle, JD1

Other Studies

2 other study(ies) available for pyrazines and bms 754807

ArticleYear
IGF-1R inhibition sensitizes breast cancer cells to ATM-related kinase (ATR) inhibitor and cisplatin.
    Oncotarget, 2016, 08-30, Volume: 7, Issue:35

    Topics: Ataxia Telangiectasia Mutated Proteins; Biomarkers, Tumor; Breast Neoplasms; Cell Survival; Cisplatin; DNA Damage; Histones; Humans; Imidazoles; Inhibitory Concentration 50; MCF-7 Cells; Oncogenes; Phosphorylation; Pyrazines; Pyrazoles; Receptor, IGF Type 1; Receptors, Somatomedin; Recombinant Proteins; RNA, Small Interfering; Triazines

2016
Antitumor effect of insulin-like growth factor-1 receptor inhibition in head and neck squamous cell carcinoma.
    The Laryngoscope, 2020, Volume: 130, Issue:6

    Topics: Head and Neck Neoplasms; Humans; Imidazoles; Insulin-Like Growth Factor I; Mouth Neoplasms; Neoplasm Staging; Pyrazines; Pyrazoles; Squamous Cell Carcinoma of Head and Neck; Treatment Outcome; Triazines; Tumor Cells, Cultured

2020